Search results for AMPK

Phospho-AMPK Alpha (Thr172) Recombinant monoclonal antibody, Proteintech, 80209-6-RR

80209-6-RR targets Phospho-AMPK Alpha (Thr172) in WB, IF, FC (Intra), CoIP, ELISA applications and shows reactivity with human, mouse samples.

Anti-PRKAA1/AMPK alpha 1 Antibody (R3S10), AntibodySystem, RHG41603

Phospho-AMPK alpha 1 (Ser496) Antibody (YA226), MedChemexpress, HY-P80451

Phospho-AMPK alpha 1 (Ser496) Antibody (YA226) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Phospho-AMPK alpha 1 (Ser496).

Phospho-AMPK alpha 2(Ser345) Antibody (YA225), MedChemexpress, HY-P80452

Phospho-AMPK alpha 2(Ser345) Antibody (YA225) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Phospho-AMPK alpha 2(Ser345).

APC Anti-AMPK alpha 1 antibody [Y365], Abcam, AB303054

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

APC Anti-AMPK beta 1 antibody [Y367], Abcam, AB317920

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

phospho-AMPK alpha-1 (Thr183) Polyclonal Antibody, Bioss, bs-5551r

Anti-AMPK alpha 1 antibody [EPR24413-70], Abcam, AB271188

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-AMPK alpha 1 (phospho S487) antibody, Abcam, AB131357

Anti-AMPK beta 2/PRKAB2 antibody [6HCLC], Abcam, AB277780

What are recombinant multiclonals? Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including: - The sensitivity of polyclonal antibodies by recognising multiple epitopes - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production View our range of recombinant multiclonal antibodies .